Article
Humanized chondroitinase ABC sensitizes glioblastoma cells to temozolomide.
The journal of gene medicine - 1 Mar 2017
Jaime-Ramirez Alena Cristina, Dmitrieva Nina, Yoo Ji Young, Banasavadi-Siddegowda Yeshavanth, Zhang Jianying, Relation Theresa, Bolyard Chelsea, Wojton Jeffrey, Kaur Balveen
Abstract excerpt
BACKGROUND: Malignant gliomas (glioblastomas; GBMs) are extremely aggressive and have a median survival of approximately 15 months. Current treatment modalities, which include surgical resection, radiation and chemotherapy, have done little to prolong the lives of GBM patients. Chondroitin sulfate proteoglycans (CSPG) are critical for cell-cell and cell-extracellular matrix (ECM) interactions and are implicated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
